TY - JOUR
T1 - Adverse events related to COVID-19 vaccines
T2 - the need to strengthen pharmacovigilance monitoring systems
AU - Shrestha, Sunil
AU - Khatri, Januka
AU - Shakya, Sujyoti
AU - Danekhu, Krisha
AU - Khatiwada, Asmita Priyadarshini
AU - Sah, Ranjit
AU - Kc, Bhuvan
AU - Paudyal, Vibhu
AU - Khanal, Saval
AU - Rodriguez-Morales, Alfonso J.
N1 - Publisher Copyright:
© 2021, The Author(s), under exclusive licence to Springer Nature Switzerland AG.
PY - 2021/8
Y1 - 2021/8
N2 - Coronavirus disease 2019 (COVID-19) is an infectious disease caused by a new species of β-coronavirus genus named severe acute respiratory syndrome coronavirus 2. The COVID-19 pandemic, which started in late 2019 and continues as at mid-2021, has caused enormous damage to health and lives globally. The urgent public health need has led to the development of vaccines against COVID-19 in record-breaking time. The COVID-19 vaccines have been widely rolled out for the masses by many countries following approval for emergency use by the World Health Organization and regulatory agencies in many countries. In addition, several COVID-19 vaccine candidates are undergoing clinical trials. However, myths, fears, rumors, and misconceptions persist, particularly in regard to adverse events. In this commentary, we describe the adverse events associated with COVID-19 vaccines and discuss why it is essential to have a functional adverse event monitoring system in this context.
AB - Coronavirus disease 2019 (COVID-19) is an infectious disease caused by a new species of β-coronavirus genus named severe acute respiratory syndrome coronavirus 2. The COVID-19 pandemic, which started in late 2019 and continues as at mid-2021, has caused enormous damage to health and lives globally. The urgent public health need has led to the development of vaccines against COVID-19 in record-breaking time. The COVID-19 vaccines have been widely rolled out for the masses by many countries following approval for emergency use by the World Health Organization and regulatory agencies in many countries. In addition, several COVID-19 vaccine candidates are undergoing clinical trials. However, myths, fears, rumors, and misconceptions persist, particularly in regard to adverse events. In this commentary, we describe the adverse events associated with COVID-19 vaccines and discuss why it is essential to have a functional adverse event monitoring system in this context.
UR - http://www.scopus.com/inward/record.url?scp=85111895141&partnerID=8YFLogxK
U2 - 10.1007/s40267-021-00852-z
DO - 10.1007/s40267-021-00852-z
M3 - Artículo
AN - SCOPUS:85111895141
SN - 1172-0360
VL - 37
SP - 376
EP - 382
JO - Drugs and Therapy Perspectives
JF - Drugs and Therapy Perspectives
IS - 8
ER -
